http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109628397-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2318
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2302
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-599
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0646
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
filingDate 2019-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2023-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2023-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109628397-B
titleOfInvention A kind of NK cell in vitro expansion culture method
abstract The invention relates to a method for culturing and amplifying human NK cells in vitro, comprising: coating a culture bottle with heparin sodium, CD16 and human immunoglobulin, collecting peripheral blood, inactivating plasma, separating mononuclear cells, using sterile Serum medium (containing autologous plasma, IL‑2, IL‑15 and IL‑18) to culture and expand cells, cell harvesting and detection and other steps. The invention does not use trophoblast cells or magnetic beads to sort and purify, and has simple operation, high safety, good amplification effect and high clinical application value.
priorityDate 2019-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414784756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833565

Total number of triples: 19.